河南科技大学第一附属医院申购PETCT汇报材料.pptVIP

选择IABP支持组6月时死亡率虽然具有2.8％的绝对差异优势，但无统计学意义（P=0.32）。尚需长期随访证实 * * 选择IABP支持和未计划IABP置入组间可能存在着置信度偏倚。因为在选择IABP支持组，心血管介入医生可能会花更多的时间处理高危冠状动脉病变，如左主干病变、左前降支开口狭窄病变等，并进行更完全的血运重建，从而导致死亡风险增加。 * 1\In patients with severe ischaemic cardiomyopathy treated with PCI, all cause-mortality was 33% at 51 months (median) 2\Elective IABP use during PCI was associated with an observed 34% reduction in long-term all-cause mortality 3\The mode of death and the putative mechanism of benefit of counterpulsation are unclear at present However, The hazard ratio at 6 months of follow-up is essentially similar to the hazard ratio